Endocrine Society Partners with Keystone Symposia to Advance Research and Education

The Endocrine Society and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science and biomedical topics, will jointly host a series of three conferences to advance endocrine research. 

The three conferences will focus on diabetes, oncology, and cardiovascular disease — hormone-related conditions that have a major impact on public health. The conference series is slated to launch in late 2026 or early 2027 and will run for at least three years. 

Each event will feature the top-flight scientific programming and luminary speakers both organizations are known for. The conferences are designed to accelerate scientific breakthroughs, catalyzing advances in foundational science that can ultimately lead to improved clinical outcomes for patients.  

“We are elated about the opportunity to collaborate with Keystone Symposia in the spirit of advancing science,” says Endocrine Society President John Newell-Price MD, PhD, FRCP. “Our basic research members value the opportunity to discuss science with other leading members of the field, and this series of conferences will offer more chances for basic researchers to interact and share ideas.” 

Keystone Symposia specializes in holding intimate conferences in relaxed environments that encourage networking and fosters connections among attendees. Building relationships with other researchers can inspire scientists to pursue new lines of inquiry and form partnerships, which can advance discoveries. 

“This partnership will be instrumental in bringing together basic scientists with clinicians and clinician-scientists to accelerate translational advances that will impact patients. We are thrilled to connect with the Endocrine Society to facilitate this common goal,” states Keystone Symposia President & CEO James Baumgartner, PhD. “These conferences will spur innovative perspectives and collaborations that integrate laboratory research with clinical insights, to ultimately yield breakthroughs against three of the most deadly diseases we face in modern society– cardiovascular disease, diabetes and cancer.” 

The Endocrine Society and Keystone Symposia plan to hold the conferences annually for at least three years.  

You may also like

  • 2025 Researchers Roundtable: Discussing Endocrine Science with the 2025 Early Investigator Award Winners

    Every year the Endocrine Society recognizes endocrinologists who are in the early stages of their research careers with the Early Investigator Awards. Endocrine News spoke to the five award recipients from around the world to find out more about their award-winning research, the award’s potential impact, as well as the biggest challenges facing them today….

  • Hoshino Wins Wayne Bardin International Travel Award

    The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne…

Find more in